Elucidating Olfactory Epithelial Anti-Viral Responses in Persistent Post-Viral Olfactory Dysfunction

阐明持续性病毒后嗅觉功能障碍中嗅觉上皮的抗病毒反应

• 批准号: 10351227
• 负责人: Carol H Yan
• 金额: $ 19.19万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-02-01 至 2027-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10351227
• 关键词: 2019-nCoV; Address; Anosmia; Antiviral Response; Area; Basal Cell; Behavior; COVID-19; COVID-19 pandemic; COVID-19 patient; Cell Differentiation process; Cells; Chronic; Clinical; Data; Development; Differentiated Gene; Environment; Functional disorder; Future; Gene Expression; Genes; Human; Immune response; Impairment; In Vitro; Individual; Infection; Inflammation; Inflammatory; Influenza; Influenza A Virus, H1N1 Subtype; Influenza A virus; Injury; Innate Immune Response; Innate Immune System; Interferon Type II; Interferon-alpha; Interferons; Interleukin-6; Knowledge; Light; Link; Measures; Mediating; Molecular; Mucous Membrane; Mucous body substance; Mus; Natural regeneration; Notch Signaling Pathway; Olfactory Epithelial Cell; Olfactory Epithelium; Olfactory Mucosa; Olfactory Pathways; Olfactory dysfunction; Outcome; Pathway interactions; Peripheral; Population; Quality of life; Research; Role; SARS-CoV-2 infection; Signal Pathway; Signal Transduction; Signaling Protein; Smell Perception; TNF gene; Testing; Therapeutic; Therapeutic Effect; Tissues; Translating; Translations; Treatment Efficacy; Undifferentiated; Up-Regulation; Viral; Virus; Virus Diseases; WNT Signaling Pathway; antagonist; body system; cell behavior; cell regeneration; cytokine; epithelium regeneration; genetic manipulation; human model; in vivo; in vivo evaluation; influenzavirus; inhibitor; interest; mouse model; neurogenesis; notch protein; novel therapeutics; olfactory neurogenesis; olfactory sensory neurons; response; stem cell differentiation; stem cell population; stem cell proliferation; stem cells; therapeutic target; transcriptome; transcriptomics

PROJECT SUMMARY: Persistent post-viral olfactory dysfunction (PVOD) is associated with a large spectrum of viruses with significant adverse impacts on quality of life. The molecular and cellular changes in the olfactory epithelium in cases of persistent PVOD have not been well characterized. Specifically, we are interested in studying the response of the olfactory stem cells which are responsible for peripheral olfactory neurogenesis and the regeneration of olfactory epithelium (OE) following injury. In the olfactory system, constitutive TNF-mediated inflammation suppresses stem cell differentiation while elevated levels of IL-6 are correlated with persistent olfactory loss. These findings raised the possibility that prolonged anti-viral signaling will inhibit olfactory stem cell differentiation and thus impair OE regeneration and result in olfactory dysfunction. In our preliminary data, we show evidence of increased type I and II interferon signaling in the olfactory mucosa of patients with SARS- CoV-2 infection and elevated expression of interferon signaling genes in the olfactory stem cells of mice infected with H1N1 influenza A. Furthermore, Notch signaling is known to be important in maintaining horizontal basal cells (one of the olfactory stem cell populations) in an undifferentiated state. Thus, we hypothesize that persistent PVOD may be related to an anti-viral olfactory epithelial response driven by the host innate immune system that translates to a chronic upregulation of inflammatory signaling genes in the olfactory stem cells and an upregulation of Notch signaling to result in stem cell quiescence and impaired regeneration of the olfactory epithelium. In the proposed studies, we will investigate the chronic anti-viral and pro-inflammatory signaling pathways in the local olfactory epithelial environment and olfactory stem cells through cytokine analysis and single cell transcriptomic sequencing (Aim 1). We will correlate expression levels of these cytokines and interferon stimulated genes with objective measures of olfactory function in humans with PVOD. Furthermore, we will assess the effects of cytokines directly on cultured olfactory stem cells in vitro. In Aim 2, we will assess the impact of viral infection on the Notch signaling pathway in olfactory stem cells using individual cell fate mapping with quantitative immunostaining and single cell transcriptomic sequencing. In vivo testing of Notch antagonists using a mouse model of viral infection will help determine the reversibility of the viral impact and the efficacy of therapeutic targeting of the Notch pathway. The incorporation of both mouse and human models in this study will allow for precise genetic manipulation and functional testing to assess olfactory epithelial cell fate as well as permit direct translation of post-viral changes in gene expression on clinical outcomes of olfaction. Together, these studies will help elucidate the cellular and molecular mechanisms for persistent post-viral olfactory loss that may shed light on potential pathways for future therapeutics.

项目摘要： 持续的病毒后嗅觉功能障碍（PVOD）与大量病毒有关 对生活质量的重大不利影响。嗅觉上皮的分子和细胞变化 持续性PVOD病例尚未得到很好的特征。具体来说，我们有兴趣研究 负责周围嗅觉神经发生的嗅觉干细胞的反应 受伤后嗅觉上皮（OE）的再生。在嗅觉系统中，构成型TNF介导 炎症抑制干细胞分化，而IL-6水平升高与持续相关 嗅觉损失。这些发现提出了延长的抗病毒信号传导会抑制嗅觉茎的可能性 细胞分化，从而损害OE再生并导致嗅觉功能障碍。在我们的初步数据中 我们显示了SARS-患者嗅觉粘膜I型和II型干扰素信号的增加的证据 COV-2感染和感染小鼠嗅觉干细胞中干扰素信号基因的表达升高 使用H1N1影响力A.此外，已知Notch信号在维持水平基本方面很重要 细胞（嗅觉干细胞群体之一）处于未分化状态。那我们假设这一持久 PVOD可能与宿主先天免疫系统驱动的抗病毒嗅觉上皮反应有关 转化为嗅觉干细胞中炎症信号基因的慢性上调和 Notch信号的上调导致干细胞静止和嗅觉的再生 上皮。 在拟议的研究中，我们将研究慢性抗病毒和促炎信号通路 在局部嗅觉上皮环境和嗅觉干细胞中，通过细胞因子分析和单细胞 转录组测序（AIM 1）。我们将将这些细胞因子和干扰素的表达水平相关联 具有PVOD人类的嗅觉功能的刺激基因。此外，我们会的 直接在体外评估细胞因子对培养的嗅觉干细胞的影响。在AIM 2中，我们将评估 病毒感染对嗅觉干细胞中Notch信号通路的影响，使用单个细胞脂肪映射 具有定量免疫染色和单细胞转录组测序。 Notch拮抗剂的体内测试 使用病毒感染的小鼠模型将有助于确定病毒影响的可逆性和效率 缺口途径的治疗靶向。在这项研究中，鼠标和人类模型的行业 将允许精确的遗传操作和功能测试评估嗅觉上皮细胞命运以及 允许直接翻译基因表达的病毒后变化在嗅觉的临床结果上。一起， 这些研究将有助于阐明持续性后嗅觉损失的细胞和分子机制 这可能揭示了未来治疗的潜在途径。